Search bioRxiv⌕ Search

Biology subjects

Ji, J. H.

Publications and source records attributed to Ji, J. H..

2 recordsLinked to original sources

Survival-associated cellular communication networks in human solid cancers

Single-cell atlases have enabled the prediction of human cell-cell communication (CCC) networks in cancer, but whether predicted communication networks have clinical significance is not well understood. Here, we integrated a pan-solid cancer scRNA-seq atlas comprising 78 cell types from 318,426 quality-controlled cells with bulk RNA-seq and clinical outcome data from The Cancer Genome Atlas (TCGA) to develop Single-cell-based Kaplan-Meier Analysis Network (SKyNet). SKyNet prioritizes ligand-receptor interactions associated with overall survival across 11 human solid cancers, predicting unique interactions not inferred by previous CCC algorithms. In pancreatic adenocarcinoma, SKyNet-predicted endothelial-pericyte interactions were associated with poor outcomes that were validated by independent spatial transcriptomics and survival cohorts. In lung adenocarcinoma, lymphatic endothelial cell interactions consisting of collagen-integrin pairs were associated with poorer survival outcomes. In kidney renal clear cell carcinoma and kidney renal papillary cell carcinoma, fibroblast communication networks displayed disparate survival associations, with the DSC2-DSG2 axis associated with better survival outcomes. Thus, SKyNet provides a hypothesis-generating framework for cell type-specific communication pathways associated with patient outcomes.

systems biology↗

The Histone Methyltransferase KMT2D promotes Natural Killer cell effector molecule release

Natural Killer (NK) cells eliminate virally infected and cancerous cells by secreting cytotoxic granules and pro-inflammatory cytokines. However, the epigenetic mechanisms that coordinate these processes in human NK cells remain poorly understood. We identified two NK deficiency (NKD) patients with mutations in the histone methyltransferase KMT2D that demonstrated impaired cytotoxicity and degranulation. CRISPR-mediated KMT2D deletion or introduction of a patient-specific mutation in healthy human NK cells was sufficient to inhibit effector functions. NK cell-specific KMT2D deletion in mice resulted in defective NK cell degranulation and IFN-{gamma} production, increasing mortality following MCMV infection. KMT2D loss reduced H3K4me1 deposition, associated with decreased levels of RAB3D. RAB3D-deficient human NK cells reduced the release of GZMB and IFN-{gamma}, without impacting intracellular levels. Thus, KMT2D acts as a conserved epigenetic regulator of mature NK cell functions, promoting rapid effector molecule release.

immunology↗